Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies (Q36093259)

12 August 2017

1 reference

title

Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies (English)

1 reference

12 August 2017

0 references

bronchiolitis obliterans

1 reference

Andrew I R Scott

1

1 reference

12 August 2017

Linda D Sharples

series ordinal

2

1 reference

12 August 2017

Susan Stewart

series ordinal

3

1 reference

12 August 2017

language of work or name

1 reference

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

65

1 reference

12 August 2017

issue

6

1 reference

12 August 2017

page(s)

761-771

1 reference

Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?

12 August 2017

cites work

1 reference

12 December 2020

Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.

1 reference

12 December 2020

Retransplantation following isolated lung transplantation

1 reference

12 December 2020

Organizing pneumonia following pulmonary transplantation and the development of obliterative bronchiolitis

1 reference

12 December 2020

Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis

1 reference

12 December 2020

A multicenter study to assess outcome following a switch in the primary immunosuppressant from cyclosporin (CYA) to tacrolimus (TAC) in lung recipients

1 reference

12 December 2020

Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry

1 reference

12 December 2020

Influence of graft ischemic time on outcomes following lung transplantation

1 reference

12 December 2020

Improved results after lung transplantation--analysis of factors.

1 reference

12 December 2020

Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome

1 reference

12 December 2020

Cyclophosphamide rescue therapy for chronic rejection after lung transplantation.

1 reference

12 December 2020

HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome

1 reference

12 December 2020

Community respiratory viral infection in adult lung transplant recipients

1 reference

12 December 2020

Chlamydia pneumoniae infection after lung transplantation.

1 reference

12 December 2020

Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab

1 reference

12 December 2020

The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation

1 reference

12 December 2020

Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation

1 reference

12 December 2020

One year analysis of an ongoing international randomized study of mycophenolate mofetil (MMF) vs azathioprine (AZA) in lung transplantation.

1 reference

12 December 2020

Medium term results of direct bronchial arterial revascularisation using IMA for single lung transplantation (SLT with direct revascularisation)

1 reference

12 December 2020

Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation

1 reference

12 December 2020

Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome

1 reference

12 December 2020

Addition of inhaled corticosteroids to systemic immunosuppression after lung transplantation: a double-blind, placebo-controlled trial.

1 reference

12 December 2020

Does donor cause of death affect the outcome of lung transplantation?

1 reference

12 December 2020

Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation

1 reference

12 December 2020

Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone

1 reference

12 December 2020

Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life

1 reference

12 December 2020

Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation

1 reference

12 December 2020

Early experience with sirolimus in lung transplant recipients with chronic allograft rejection

1 reference

12 December 2020

Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation

1 reference

12 December 2020

Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients

1 reference

12 December 2020

Lung retransplantation for bronchiolitis obliterans syndrome: long-term follow-up in a series of 15 recipients

1 reference

12 December 2020

Statin Use Is Associated with Improved Function and Survival of Lung Allografts

1 reference

12 December 2020

Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome

1 reference

12 December 2020

Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation

1 reference

12 December 2020

Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations

1 reference

12 December 2020

Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).

1 reference

12 December 2020

Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients

1 reference

12 December 2020

Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study

1 reference

12 December 2020

Rabbit antithymocyte globulin versus OKT3 induction therapy after heart-lung and lung transplantation: effect on survival, rejection, infection, and obliterative bronchiolitis

1 reference

12 December 2020

Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients

1 reference

12 December 2020

Surveillance transbronchial lung biopsies: implication for survival after lung transplantation

1 reference

12 December 2020

The impact of cytolytic therapy on bronchiolitis obliterans syndrome

1 reference

12 December 2020

Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation

1 reference

12 December 2020

The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000

1 reference

12 December 2020

Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation.

1 reference

12 December 2020

Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation

1 reference

12 December 2020

Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation

1 reference

12 December 2020

Risk factors for the development of obliterative bronchiolitis after lung transplantation

1 reference

12 December 2020

Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome

1 reference

12 December 2020

Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management

1 reference

12 December 2020

Chlamydia pneumoniae serology in donors and recipients and the risk of bronchiolitis obliterans syndrome after lung transplantation.

1 reference

12 December 2020

1 reference

12 December 2020

Respiratory viruses and chronic rejection in lung transplant recipients.

1 reference

12 December 2020

Bronchiolitis obliterans syndrome and additional costs of lung transplantation

1 reference

12 December 2020

Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans.

1 reference

12 December 2020

HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction

1 reference

12 December 2020

Intermediate-term results after en bloc double-lung transplantation with bronchial arterial revascularization. Bordeaux Lung and Heart-Lung Transplant Group

1 reference

12 December 2020

Statins as a newly recognized type of immunomodulator

1 reference

12 December 2020

Lung retransplantation: institutional report on a series of twenty patients

1 reference

12 December 2020

A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.

1 reference

12 December 2020

Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation

1 reference

12 December 2020

Retransplantation of the lung. A single center experience.

1 reference

12 December 2020

The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation.

1 reference

12 December 2020

Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation

1 reference

12 December 2020

Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody

1 reference

12 December 2020

Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans

1 reference

12 December 2020

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria

1 reference

12 December 2020

Aerosolized cyclosporine in lung recipients with refractory chronic rejection

1 reference

12 December 2020

Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation

1 reference

12 December 2020

The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study

1 reference

12 December 2020

Rapamycin inhibits development of obliterative airway disease in a murine heterotopic airway transplant model.

1 reference

12 December 2020

Risk factors for bronchiolitis obliterans: a systematic review of recent publications

1 reference

12 December 2020

Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation

1 reference

12 December 2020

Parainfluenza virus infection in adult lung transplant recipients: an emergent clinical syndrome with implications on allograft function

1 reference

12 December 2020

Analysis of risk factors for the development of bronchiolitis obliterans syndrome

1 reference

12 December 2020

Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation.

1 reference

12 December 2020

Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients

1 reference

12 December 2020

Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?

1 reference

12 December 2020

Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation

1 reference

12 December 2020

Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group

1 reference

12 December 2020

Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches

1 reference

12 December 2020

Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation

1 reference

12 December 2020

10.2165/00003495-200565060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

1038300761

0 references

1 reference